Wild, M.; Karner, D.; Eickhoff, J.; Wagner, S.; Kicuntod, J.; Chang, W.; Barry, P.; Jonjić, S.; Lenac Roviš, T.; Marschall, M.
Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers. Pharmaceutics 2023, 15, 2680.
https://doi.org/10.3390/pharmaceutics15122680
AMA Style
Wild M, Karner D, Eickhoff J, Wagner S, Kicuntod J, Chang W, Barry P, Jonjić S, Lenac Roviš T, Marschall M.
Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers. Pharmaceutics. 2023; 15(12):2680.
https://doi.org/10.3390/pharmaceutics15122680
Chicago/Turabian Style
Wild, Markus, Dubravka Karner, Jan Eickhoff, Sabrina Wagner, Jintawee Kicuntod, William Chang, Peter Barry, Stipan Jonjić, Tihana Lenac Roviš, and Manfred Marschall.
2023. "Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers" Pharmaceutics 15, no. 12: 2680.
https://doi.org/10.3390/pharmaceutics15122680
APA Style
Wild, M., Karner, D., Eickhoff, J., Wagner, S., Kicuntod, J., Chang, W., Barry, P., Jonjić, S., Lenac Roviš, T., & Marschall, M.
(2023). Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers. Pharmaceutics, 15(12), 2680.
https://doi.org/10.3390/pharmaceutics15122680
